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早有报道指出动脉粥样硬化的病灶中存在坏死的巨噬细胞，但巨噬细胞坏死对动脉
粥样硬化的影响目前尚未明了。在本论文中，我们在小鼠模型中观察了介导细胞坏



































         
         
Necrotic death of macrophages has long been known to be present in
atherosclerotic lesions but has never been studied at the molecular level. We
examined the role of receptor interacting protein (RIP) 3, a mediator of necrotic
cell death, in atherosclerosis and found that RIP3-/-;Ldlr-/- mice had no
phenotypic difference from RIP3+/+;Ldlr-/- mice in early atherosclerosis but
exhibited significant reduction in advanced atherosclerotic lesions. Similar results
were observed in Apoe-/- background mice. Analysis of bone marrow
transplantation experiments revealed that loss of RIP3 expression from bone
marrow-derived cells is responsible for the reduced disease progression. Based
on the data from electron microscopic analysis of macrophage death in the early
and advanced lesion, We found no difference in macrophage apoptosis in the
early and advanced lesion between RIP3-/-;Ldlr-/- and RIP3+/+;Ldlr-/- mice, we
also found no difference in macrophage primary necrosis in the early lesion
between the two groups, but a significant reduction of macrophage primary
necrosis in the advanced lesion of RIP3-/- mice was found. In vitro studies
showed that RIP3 deletion had no effect on oxidized LDL-induced macrophage
apoptosis but prevented macrophage primary necrosis induced by oxLDL plus
zVAD (pan caspase inhibitor). Our research further suggests that primary
necrosis can occur in vitro in response to oxidized LDL under the condition of
caspase 8 inhibition or RIP3 over-expression to certain threshold. When Caspase
8 and RIP3 expression level in the early and advanced lesions was measured,
neither Caspase 8 expression level nor its activity was up-regulated in the
development of athesrosclerotic lesion. In contrast, RIP3 up-regulation in
macrophages in the lesion was detected when the lesion developed. Over-
expression of RIP3 in the lesional macrophages is likely the cause that leads to













inflammatory response and larger lesion area. Our data demonstrated that
primary necrosis of macrophages is pro-atherogenic in advanced atherosclerosis
development. Revealing the role of RIP3-mediated macrophage primary necrosis
in the development of atherosclerosis helps find new therapeutic targets for
atherosclerosis.
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